We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Court Orders Special Master In Amgen, Roche Case

Law360 (March 26, 2008, 12:00 AM EDT) -- A federal court has ordered the appointment of a special master in a patent dispute between Amgen Inc. and Roche Holding AG as it considers whether to permanently enjoin Roche from selling the anemia drug Mircera in the U.S.

District Judge William G. Young of the U.S. District Court for the District of Massachusetts said Wednesday that the special master would weigh “price parity as well as the respective dose conversion ratios for Mircera and Epogen,” Amgen's anemia drug.

Amgen accused Roche of infringing several patents...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.